136 related articles for article (PubMed ID: 32111757)
1. Butyric Acid in Saliva of Chronic Periodontitis Patients Induces Transcription of the EBV Lytic Switch Activator BZLF1: A Pilot Study.
Koike R; Nodomi K; Watanabe N; Ogata Y; Takeichi O; Takei M; Kaneko T; Tonogi M; Kotani AI; Imai K
In Vivo; 2020; 34(2):587-594. PubMed ID: 32111757
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas endodontalis reactivates latent Epstein-Barr virus.
Makino K; Takeichi O; Imai K; Inoue H; Hatori K; Himi K; Saito I; Ochiai K; Ogiso B
Int Endod J; 2018 Dec; 51(12):1410-1419. PubMed ID: 29858508
[TBL] [Abstract][Full Text] [Related]
3. The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification.
Imai K; Inoue H; Tamura M; Cueno ME; Inoue H; Takeichi O; Kusama K; Saito I; Ochiai K
Biochimie; 2012 Mar; 94(3):839-46. PubMed ID: 22178321
[TBL] [Abstract][Full Text] [Related]
4. PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.
Lupey-Green LN; Moquin SA; Martin KA; McDevitt SM; Hulse M; Caruso LB; Pomerantz RT; Miranda JL; Tempera I
Virology; 2017 Jul; 507():220-230. PubMed ID: 28456021
[TBL] [Abstract][Full Text] [Related]
5. Switching of EBV cycles between latent and lytic states.
Murata T; Tsurumi T
Rev Med Virol; 2014 May; 24(3):142-53. PubMed ID: 24339346
[TBL] [Abstract][Full Text] [Related]
6. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
7. A role for the nucleosome assembly proteins TAF-Iβ and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation.
Mansouri S; Wang S; Frappier L
PLoS One; 2013; 8(5):e63802. PubMed ID: 23691099
[TBL] [Abstract][Full Text] [Related]
8. Histone acetylation and reactivation of Epstein-Barr virus from latency.
Jenkins PJ; Binné UK; Farrell PJ
J Virol; 2000 Jan; 74(2):710-20. PubMed ID: 10623733
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.
Shimozuma Y; Ito T; Inokuchi M; Uchikoshi M; Miyashita M; Nozawa H; Shimazaki T; Hiroishi K; Imawari M
J Med Virol; 2010 Dec; 82(12):2064-72. PubMed ID: 20981794
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
11. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
12. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.
Needham J; Adamson AL
Virus Genes; 2019 Dec; 55(6):779-785. PubMed ID: 31552622
[TBL] [Abstract][Full Text] [Related]
13. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
14. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
16. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphohistiocytosis.
Imajoh M; Hashida Y; Murakami M; Maeda A; Sato T; Fujieda M; Wakiguchi H; Daibata M
J Med Virol; 2012 Jun; 84(6):940-6. PubMed ID: 22511310
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]